Remove FDA Remove Governance Remove Prescription Drug Pricing
article thumbnail

Lower Prescription Drug Prices – A Tri-Partisan Call Across America

Health Populi

A new poll jointly conducted by Politico and the Harvard Chan School of Public Health bolsters my read on the latter issue – prescription drug pricing, which has become a mass popular culture union. This is the tactic that most Americans say could lower prescription drug prices. Why should U.S.

article thumbnail

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Health Populi

IQVIA rightly calls out digital therapeutics (DTx) in this year’s report, noting the growth of mobile apps and digital tools submitted to the FDA for clearance or approvals. The first FDA cleared DTx was reSET from Pear Therapeutics, cleared in November 2018. Thus far, the FDA has been welcoming to these concepts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

Health Populi

Eli Lilly is currently under investigation for working, under your tenure, with other drug companies to needlessly raise the price of insulin.” ” Second, the National Academy of Science published a well-researched report supporting government prescription drug price negotiation.

article thumbnail

Rx 2018: A New Era of Specialty Drugs, Telehealth, Mobile Apps and Value, IQVIA Reports

Health Populi

Health Populi’s Hot Points: The big wild card in forecasting what prescription drug spending will look like in the U.S. is just how aggressive Dr. Alex Azar at the Department of Health and Human Services, and Dr. Scott Gottlieb at FDA, want to be regarding drug pricing.

article thumbnail

The State of the Union for Prescription Drug Prices

Health Populi

voters’ priorities, across political party – prescription drug prices. voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Few issues unite U.S.

article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass. Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass.

article thumbnail

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

This is what happened to pharma stock prices on Friday after President Trump and Secretary of Health and Human Services Alex Azar outlined their new policies focusing on prescription drug prices. Seniors and government programs over-paying for drugs. The graph is the Nasdaq U.S.